2007 JASN IMPACT FACTOR 7.111	HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP
advanced	CURRENT ISSUE	ARCHIVES	JASN Express	ONLINE SUBMISSION

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by BAID, S. Articles by COLVIN, R. B. Search for Related Content PubMed PubMed Citation Articles by BAID, S. Articles by COLVIN, R. B.

Renal Thrombotic Microangiopathy Associated with Anticardiolipin Antibodies in Hepatitis C-Positive Renal Allograft Recipients

SEEMA BAID^*, MANUEL PASCUAL^*,, WINFRED W. WILLIAMS, JR.^*,, NINA TOLKOFF-RUBIN^*,, STEPHEN M. JOHNSON^§, BERNARD COLLINS^§, RAYMOND T. CHUNG, FRANCIS L. DELMONICO, A. BENEDICT COSIMI and ROBERT B. COLVIN^§

^* Renal Unit, Massachusetts General Hospital, Boston, Massachusetts.
Transplantation Unit, Massachusetts General Hospital, Boston, Massachusetts.
Gastrointestinal Unit, Massachusetts General Hospital, Boston, Massachusetts.
^§ Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts.

Correspondence to Dr. Seema Baid, Renal Unit, Massachusetts General Hospital, 100 Charles River Plaza, Fifth floor, Boston, MA 02114. Phone: 617-726-3772; Fax: 617-726-7491.

Abstract. Hepatitis C virus (HCV) infection has been associated with de novo or recurrent membranoproliferative glomerulonephritis and acute transplant glomerulopathy in transplanted kidneys. Recently, anticardiolipin antibodies (ACA) have been linked with chronic HCV infection. A few reports have suggested an association between ACA and renal allograft thrombosis. This study examines the clinical and pathologic features of HCV-positive renal allograft recipients at our institution. From 1990 to 1996, 379 kidney transplants were performed. We identified 18 recipients (4.8%) with HCV-positive serology pretransplant. Determination of IgG and IgM ACA was performed by enzyme-linked immunosorbent assay, using pretransplant sera. Among the 18 patients, five patients presented with biopsy-proven de novo renal thrombotic microangiopathy (RTMA), occurring 5 to 120 d (median, 14 d) after transplant. No differences in pretransplant characteristics were observed between patients with (n = 5) or without (n = 13) RTMA. All five patients had a positive ACA test (either IgG or IgM titer > 2 SD above normal), compared with only one of 13 patients without RTMA. The mean value for IgG ACA was significantly higher in the RTMA patients than in patients without RTMA (22.9 ± 14.1 versus 6.9 ± 4.9 IgG phospholipid units, P = 0.02); however, there were no significant differences in IgM ACA titers. Rheumatoid factor and complement C4 levels were normal in pretransplant sera of patients with RTMA. Patients with RTMA had their cyclosporine withdrawn (four of five) or the dose was decreased (one of five), and one of five underwent plasmapheresis. Four of five patients died within 5 yr after transplant, compared with no deaths in the other 13 patients. Finally, as a control group, seven HCV-negative renal allograft recipients who presented with RTMA/hemolytic uremic syndrome during the same time period were found to have normal ACA values (IgG or IgM). RTMA associated with ACA in HCV-positive renal allograft recipients may represent a new clinical entity. The occurrence of this syndrome may have deleterious consequences for patient and graft survival.

This article has been cited by other articles:

				S. M. Meehan, A. Chang, A. Khurana, R. Baliga, P. V. Kadambi, and B. Javaid Pauci-immune and Immune Glomerular Lesions in Kidney Transplants for Systemic Lupus Erythematosus Clin. J. Am. Soc. Nephrol., September 1, 2008; 3(5): 1469 - 1478. [Abstract] [Full Text] [PDF]

				N. A. Terrault and D. B. Adey The Kidney Transplant Recipient with Hepatitis C Infection: Pre- and Posttransplantation Treatment Clin. J. Am. Soc. Nephrol., May 1, 2007; 2(3): 563 - 575. [Abstract] [Full Text] [PDF]

				H. Nishi, N. Hanafusa, Y. Kondo, M. Nangaku, Y. Sugawara, M. Makuuchi, E. Noiri, and T. Fujita Clinical Outcome of Thrombotic Microangiopathy after Living-Donor Liver Transplantation Treated with Plasma Exchange Therapy Clin. J. Am. Soc. Nephrol., July 1, 2006; 1(4): 811 - 819. [Abstract] [Full Text] [PDF]

				R. J. Crew, J. Radhakrishnan, D. J. Cohen, L. Stern, M. Goldstein, M. Hardy, V. D. D'Agati, and G. S. Markowitz De novo thrombotic microangiopathy following treatment with sirolimus: report of two cases Nephrol. Dial. Transplant., January 1, 2005; 20(1): 203 - 209. [Full Text] [PDF]

				R Cervera, R A Asherson, M L Acevedo, J A Gomez-Puerta, G Espinosa, G de la Red, V Gil, M Ramos-Casals, M Garcia-Carrasco, M Ingelmo, et al. Antiphospholipid syndrome associated with infections: clinical and microbiological characteristics of 100 patients Ann Rheum Dis, October 1, 2004; 63(10): 1312 - 1317. [Abstract] [Full Text] [PDF]

				G Espinosa, S Bucciarelli, R Cervera, M Lozano, J-C Reverter, G de la Red, V Gil, M Ingelmo, J Font, and R A Asherson Thrombotic microangiopathic haemolytic anaemia and antiphospholipid antibodies Ann Rheum Dis, June 1, 2004; 63(6): 730 - 736. [Abstract] [Full Text]

				R A Asherson and R Cervera Antiphospholipid antibodies and infections Ann Rheum Dis, May 1, 2003; 62(5): 388 - 393. [Abstract] [Full Text] [PDF]

				J. Hambleton, L. L. Leung, and M. Levi Coagulation: Consultative Hemostasis Hematology, January 1, 2002; 2002(1): 335 - 352. [Abstract] [Full Text]

				J. M. MORALES and J. M. CAMPISTOL Transplantation in the Patient with Hepatitis C J. Am. Soc. Nephrol., July 1, 2000; 11(7): 1343 - 1353. [Full Text]

				L. MURER, G. ZACCHELLO, D. BIANCHI, R. DALL'AMICO, G. MONTINI, B. ANDREETTA, M. PERINI, E. C. DOSSI, G. ZANON, and F. ZACCHELLO Thrombotic Microangiopathy Associated with Parvovirus B 19 Infection after Renal Transplantation J. Am. Soc. Nephrol., June 1, 2000; 11(6): 1132 - 1137. [Abstract] [Full Text]

Copyright © 2008 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673